Lumagem Molecular Breast Imaging System
Camera, Scintillation (Gamma). 510(k) K111791, from Gamma Medica-Ideas Incorporated (Sunnyvale, CA). Product code IYX, class 1.
As of Nov 17, 2026, K111791 is an FDA 510(k) held by Gamma Medica-Ideas Incorporated, substantially equivalent on Sep 23, 2011 after 88 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Sep 23, 2011
- Review time: 88 days
- Recalls: 0
- Cited as a predicate by: 1 device
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe LumaGEM TM Molecular Breast Imaging System is intended to measure and image the distribution of radionuclides by means of photon detection in order to aid in the evaluation of lesions in the breast tissue and other small body parts.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Lumagem Scintillation CameraK993813 · Gamma Medica · Jan 18, 2000
- Discovery Nm 750BK102231 · Ge Medical Systems Israel, Functional Imaging · Nov 3, 2010
Cited as a Predicate
1 later 510(k) summary names this device as a predicate- Ergo Imaging SystemK123408 · Digirad Corp. · Jan 15, 2013
Other IYX Clearances
The newest 510(k)s for the same product code; see every IYX device- QDOSE® Multi-purpose Voxel Dosimetry (Personalized Dosimetry in Molecular Radiotherapy)K230221 · Versant Medical Physics and Radiation Safety · Aug 28, 2023
- 3D-RD-SK212587 · Radiopharmaceutical Imaging and Dosimetry, LLC · Feb 22, 2023
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 27, 2011
- Review panel
- Radiology
- Regulation
- 21 CFR 892.1100
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files